Chengdu Kanghua Biological Products (300841) — Capital Reinvestment Ratio
Chengdu Kanghua Biological Products (300841) has a Capital Reinvestment Ratio of 0.16x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥92.89 Million) in capital expenditures (CN¥14.49 Million). See Chengdu Kanghua Biological Products (300841) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Chengdu Kanghua Biological Products Capital Reinvestment Ratio (2015–2024)
This chart tracks Chengdu Kanghua Biological Products's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Chengdu Kanghua Biological Products (2015–2024)
Year-by-year Capital Reinvestment Ratio for Chengdu Kanghua Biological Products from 2015 to 2024. For live market cap and broader valuation context, see Chengdu Kanghua Biological Products (300841) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | CN¥572.24 Million | CN¥144.30 Million | ▼ -8.0% |
| 2023 | 0.27x | CN¥573.98 Million | CN¥157.27 Million | ▼ -87.3% |
| 2022 | 2.15x | CN¥194.99 Million | CN¥419.23 Million | ▼ -11.0% |
| 2021 | 2.42x | CN¥130.33 Million | CN¥314.94 Million | ▲ +558.3% |
| 2020 | 0.37x | CN¥369.56 Million | CN¥135.67 Million | ▲ +179.1% |
| 2019 | 0.13x | CN¥182.73 Million | CN¥24.04 Million | ▼ -78.2% |
| 2018 | 0.60x | CN¥57.35 Million | CN¥34.58 Million | ▲ +1096.9% |
| 2017 | 0.05x | CN¥89.96 Million | CN¥4.53 Million | ▼ -92.8% |
| 2016 | 0.70x | CN¥2.64 Million | CN¥1.86 Million | ▲ +48.7% |
| 2015 | 0.47x | CN¥6.51 Million | CN¥3.07 Million | — |